Iparomlimab and Tuvonralimab (QL1706)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Iparomlimab and Tuvonralimab (QL1706)
Treatment and conditionWhere it standsTrials
Iparomlimab and Tuvonralimab (QL1706) for endometrial neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1